MarkellaVZanniMD
Endocrinology • Boston, MADiabetes, Lipid Metabolism
Instructor in Medicine, Massachusetts General Hospital
Are you Dr. Zanni?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 83 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
0 Emerson Pl
Suite 112
Boston, MA 02114Phone+1 617-726-6813Fax+1 617-726-1241
Summary
- Dr. Markella Zanni, MD is an endocrinologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Massachusetts General Hospital and is an Instructor in Medicine at Massachusetts General Hospital.
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2010
Brigham and Women's HospitalResidency, Internal Medicine, 2004 - 2007
Harvard Medical SchoolClass of 2004
Certifications & Licensure
MA State Medical License 2007 - 2026- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study Start of enrollment: 2012 Feb 01
- Inflammation and Cardiovascular Health in Women Start of enrollment: 2020 Feb 03
Publications & Presentations
PubMed
- Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leverag...Steven K Grinspoon, Markella V Zanni, Virginia A Triant, Amy Kantor, Triin Umbleja
The Lancet. HIV. 2025-01-17 - 1 citationsProteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV.Edgar T Overton, Amy Kantor, Kathleen V Fitch, Mosepele Mosepele, Judith A Aberg
AIDS. 2025-01-01 - Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, Kathleen V Fitch, Carl J Fichtenbaum
JAMA Cardiology. 2024-12-11
Press Mentions
Study Highlights Gaps in CVD Risk Models for People with HIVJanuary 19th, 2025- Gulati: ASPC Summit to Explore ‘Protecting the Heart of One and All’July 22nd, 2021
REPRIEVE MR: Characterizing Cardiac Dysfunction in HIV and Testing the Effect of StatinsJuly 1st, 2017- Join now to see all
Grant Support
- Effects Of Tnf-A Antagonism In Patients With Obesity And Metabolic DysregulationNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Effects Of Tnf-Alpha Antagonism In Patients With Obesity And Metabolic DysregulatNational Institute Of Diabetes And Digestive And Kidney Diseases2010
Other Languages
- Greek
